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Background: There is a growing body of literature on evidence-informed priority setting. However, the literature on the use 
of evidence when setting healthcare priorities in low-income countries (LICs), tends to treat the healthcare system (HCS) as a 
single unit, despite the existence of multiple programs within the HCS, some of which are donor supported. 
Objectives: (i) To examine how Ugandan health policy-makers define and attribute value to the different types of evidence; 
(ii) Based on 6 health programs (HIV, maternal, newborn and child health [MNCH], vaccines, emergencies, health systems, 
and non- communicable diseases [NCDs]) to discuss the policy-makers’ reported access to and use of evidence in priority 
setting across the 6 health programs in Uganda; and (iii) To identify the challenges related to the access to and use of evidence.
Methods: This was a qualitative study based on in-depth key informant interviews with 60 national level (working in 6 
different health programs) and 27 sub-national (district) level policy-makers. Data were analysed used a modified thematic 
approach. 
Results: While all respondents recognized and endeavored to use evidence when setting healthcare priorities across the 6 
programs and in the districts; more national level respondents tended to value quantitative evidence, while more district level 
respondents tended to value qualitative evidence from the community. Challenges to the use of evidence included access, 
quality, and competing values. Respondents from highly politicized and donor supported programs such as vaccines, HIV 
and maternal neonatal and child health were more likely to report that they had access to, and consistently used evidence in 
priority setting.
Conclusion: This study highlighted differences in the perceptions, access to, and use of evidence in priority setting in the 
different programs within a single HCS. The strong infrastructure in place to support for the access to and use of evidence 
in the politicized and donor supported programs should be leveraged to support the availability and use of evidence in the 
relatively under-resourced programs. Further research could explore the impact of unequal availability of evidence on priority 
setting between health programs within the HCS. 
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Implications for policy makers
• Since it improves the quality of priority setting decisions, evidence is critical when setting healthcare priorities.
• Although there are global efforts to strengthen the evidence base for priority setting, decision-makers in low-income countries (LICs) still 
experience constraints in accessing and using evidence in priority setting.
• The availability, accessibility and use of evidence varies between programs depending on whether or not the program is politicized or donor 
supported. 
• The infrastructure and resources that are available to the programs that are well-supported should be leveraged to strengthen the use of evidence 
in priority setting within all programs in the whole healthcare system (HCS).
Implications for the public
Priority setting and resource allocation are critical in low-income countries (LICs) that have limited health resources. However, priority setting can easily 
be influenced by several unaccepted subjective factors which can be mitigated by using evidence. Many LICs have limited access to quality evidence. We 
found that since healthcare systems (HCSs) in LICs still have donor supported programs, these programs tend to have more accessible, quality evidence 
compared to the other programs. These differences imply a possibility that priority setting in the other programs is liable to being influenced by other 
factors. It would be beneficial and efficient to leverage the resources that are available to the well-resourced programs and use them to improve the 
evidence availability, quality and access for the entire HCS. The additional challenges to the use of evidence in priority setting should also be addressed 
so as to ensure that the generated evidence is used to improve health sector prioritization.
Key Messages 
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Background
Evidence[1], in its myriad forms, is perceived as a critical part of 
policy-making in health.1,2 Priority setting is a critical process 
within the health policy-making and implementation cycle. 
Systematic healthcare priority setting[2] involves an explicit 
process of selecting which health interventions to pursue, for 
the purposes of resource allocation. According to the literature, 
using evidence (eg, burden of disease, cost-effectiveness, and 
cost-benefit assessments) when setting healthcare priorities 
promotes objectivity, improves consistency, and strengthens 
the validity of the prioritization process and the decisions. 
The result is an improved quality of decisions.3,4 The use of 
evidence in priority setting is therefore critical, especially in 
low-income countries (LICs) where resources are scarce.5-8 
There have been several global level calls to improve 
evidence-informed policy-making. For example, the 
statement from the 2004 Ministerial Summit on Health 
Research in Mexico City; the resolution from the 58th World 
Health Assembly which urged member states to strengthen 
knowledge transfer mechanisms; the 2008 Bamako Statement 
that called for countries to ensure that decision-makers 
have access to relevant evidence1,2; the World Report on 
Knowledge for Better Health9 and the latest call which came 
with the sustainable development goals where the collection 
and dissemination of high quality evidence is recognized as 
a key element in facilitating effective planning, follow-up 
and review of the implementation of the 2030 agenda for 
sustainable development.10 
The response to these calls has been the development of 
several initiatives at the global, regional and national that 
support the generation and use of evidence in decision-
making. Examples of global level initiatives include the 
WHO’s–CHOosing Interventions that are Cost-Effective,11 
Grading of Recommendations Assessment, Development 
and Evaluation,12 the Disease control priorities project.13 At 
the regional level initiatives such as the Evidence Informed 
Policy Network,3 and the International Decision Support 
Initiative,14 are working to strengthen decision-makers access 
to and use of evidence in several countries.3,10 Efforts at the 
national level have focused on improving the quality of the 
available evidence eg, in Ethiopia15; as well as facilitating 
the use of evidence in policy dialogues by conducting rapid 
reviews and providing readily accessible evidence to policy-
makers eg, in Uganda.10 There have been concurrent efforts 
to facilitate evidence based priority setting at the sub-national 
levels through projects such as the Community and District 
Empowerment for Scale-up in Uganda16,17 and the data-
informed platform for health in India, Nigeria and Ethiopia.18 
To some extent, these strategies have increased the availability 
and use of evidence, yet there are still circumstances in which 
evidence is either lacking, inaccessible, underutilized, or lacks 
credibility.19 For example, the limited resources that hamper 
priority setting in LICs may also contribute to a lack of 
credible evidence.19-22 Furthermore, there are reported cases 
where evidence has been disregarded by decision-makers 
whose priorities lie elsewhere.1,22-24
Evidence is thought to be key to improving the quality of 
priority setting and resource allocation decisions.25 Since it 
is often considered to be objective, evidence is thought to 
provide means through which personal interests and values 
which may have undue influence on priority setting, can be 
mitigated.4,24-28 However, there is a paucity of literature on how 
low-income country decision-makers define, access and use 
evidence when identifying healthcare priorities. To date most 
of the literature on the use of evidence in LICs has focused 
on policy-making1-3,9-11 and not specifically on priority setting 
– which is a critical component of the health policy-making 
cycle. Some of these studies have, for example identified 
barriers and facilitators of evidence-informed decision-
making,5,14,22,26 while others have focused on approaches 
and tools to facilitate the use of evidence10,12-16 in LICs. The 
benefits of using evidence in healthcare priority setting may be 
particularly critical in LICs where priority setting is thought 
to be fraught with uncertainties, and can be easily influenced 
by the interests and agendas of various stakeholders.24-28 
The meagre literature on the use of evidence in priority 
setting in LICs has focused on the health sector as a unit. 
However, in countries such as Uganda, the health sector 
comprises of different health programs (see Supplementary 
file 1) which may, in some cases, have additional funding 
(and priority setting) mechanisms.29-34 In many cases, 
programs with different funding mechanisms have different 
information gathering and reporting mechanisms, depending 
on the funding agencies.34 Might there be differences in the 
way different policy-makers conceptualize, value, access and 
use evidence in their prioritization processes? This paper 
responds to this question.
The objectives of this paper are (i) To examine how 
Ugandan health policy-makers define and attribute value 
to the different types of evidence; (ii) Based on 6 health 
programs (HIV, maternal, newborn and child health 
[MNCH], Vaccines, emergencies, health systems, and non-
communicable diseases [NCDs]) to discuss the policy-
makers’ reported access to and use of evidence in priority 
setting across the 6 health programs in Uganda; and (iii) 
To identify the challenges related to the access to and use of 
evidence. This paper also highlights key points of similarity 
and difference between the health programs.
Methods
Setting
This paper is part of a large study whose purpose was to 
describe and evaluate priority setting across 6 programs and 
in 3 districts in Uganda. The large study employed qualitative 
methods namely key informant interviews and a review of 
documents. The study was conducted between March 2014 
and March 2016 at the national and sub-national levels 
(districts) in Uganda. 
Study Sample and Sampling Strategy
We sampled respondents who were knowledgeable of 
priority setting at the national and district levels (policy-
makers and development partners-donors). A mixture of 
purposeful and snowball sampling strategies was used.30 At 
the national level we targeted respondents who were involved 
in priority setting with focus on specific programs (HIV, 
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MNCH, Vaccines, emergencies, health systems, and NCDs). 
The initial respondents (policy-makers heading any of the 
6 programs), identified subsequent respondents who they 
thought were knowledgeable. The interviewees were asked to 
identify additional respondents until we achieved theoretical 
saturation—no new themes emerged from subsequent 
interviews.
Three districts were included in the study. The districts 
were sampled for regional representation and duration since 
the district was formed (the old [more than 20 years], the 
intermediate [over 10 years], and new districts [less than 
10 years]). Within each district, we purposed to recruit all 
members of the district health. Using purposeful and snowball 
sampling, the initial respondent was the Director of district 
health services who identified subsequent respondents. 
We interviewed a total of 60 respondents at the national 
level (including development assistance partners (DAPs) 
or donors and policy-makers) and 27 at the sub-national 
(district) level (Table).
The reviewed documents included 3 health sector strategic 
plans (2000-2015), 14 Annual health sector reports (2001-
2015), 2 National health policy statements (1999-2010), 
Meeting minutes (2009-2015) and media reports (2005-2015). 
These were aligned with the health strategic planning cycles.
Data Collection and Analysis
The interviews were conducted by a trained research assistant 
and the principle investigator using a pilot-tested interview 
guide (see Supplementary file 2). The interview guide 
included: a definition of priority setting and its relevance, 
followed with general questions about the priority setting 
process and specific questions and probing about the use 
of evidence in the prioritization process. Interviews were 
conducted in English language and lasted between 30-45 
minutes. All interviews were audio recorded with permission 
from the respondents, and were transcribed verbatim. 
NVIVO-10 was used to analyze the transcribed data. Three 
members of the research team coded one interview; after the 
independent coding, they met and discussed the code names 
each identified from the interview. Codes that were consistent 
were adopted for use; codes where there was no agreement 
were discussed and an agreed upon code identified. The edited 
list of codes was then used for to guide the coding the rest of 
the interviews.35,36 However, an open stance was maintained 
throughout the process and any codes that emerged during the 
process were continually discussed and agreed on codes were 
added to the code book. While several themes about priority 
setting emerged from the data (see Supplementary file 3), 
this paper focuses on the “evidence” theme. In the analyzing 
this theme, the following dimensions of evidence emerged 
from the data: definition of evidence; Value of different types 
of evidence; sources of evidence; role/use of evidence; related 
challenges. Further analysis involved assessing the degree 
of agreement and divergence between responses from the 
different programs and the levels of decision-making. Initial 
interpretations of the findings were presented, discussed and 
validated by the policy-makers in 2017.
Results
The first section is organized according to the categories that 
emerged from the data namely; “definitions of evidence,” 
“the value of evidence,” “the sources of evidence,” “the role 
of evidence in priority setting” and “the challenges with the 
access to and use of evidence. The last section of the results 
provides an analysis of the relationship between the different 
categories and sub-categories. Illustrative quotes are provided 
in text and in an additional file (see Supplementary file 4). 
Identifiers for the quotes include the designation of the 
respondent vis: Respondents from the Ministry of health: 
MoH, the DAPs/donors: DAP, the district respondents: D; 
this is followed by a randomly allocated number. 
Definitions of Evidence 
Respondents were not provided with a definition for evidence, 
hence one theme that emerged from analyzing the theme on 
evidence was the variety of terms that interviewees involved 
in this study used to refer to evidence. As explained by one 
respondent; 
“what constitutes as ‘evidence’ for one person may not be 
viewed as appropriate evidence by another…” (DAP_1). 
As such, terminology used by the respondents ranged from: 
objective terms such as data and statistics on one hand, and 
subjective terms such as personal knowledge and experience 
on the other. For some respondents, evidence encompassed 
everything from quantifiable epidemiological data to 
subjective immeasurable concepts such as well-being. In their 
responses, respondents focused on the aspects of evidence 
that they value most. Broadly speaking, however, their uses 
of the term can be categorized as quantitative or qualitative, 
with national-level respondents prioritizing the former and 
Table. Respondents by Program and District














Abbreviations: MNCH, maternal, newborn and child health; NCD, non-
communicable disease. 
a Health systems respondents also spoke to almost all the other cases; but 
were specifically asked about the health system.
b District C was the oldest district, it had all their administrative positions 
filled as compared to the newer districts.
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sub-national–level respondents tending to prefer the latter. 
Both types of evidence are discussed below.
Quantitative Evidence
Overall, respondents showed a preference for evidence with 
easily collectable and analyzable metrics. These also reported 
that they privileged quantitative evidence because it was easily 
understood. As they explained, quantitative information 
such as economic evidence, mortality and morbidity rates, 
and burden of disease are (a) comparatively easy to measure 
(b) favorable to politicians and (c) well correlated with 
opportunities for future funding: 
“…You have to show them (the politicians) figures. When 
they see the numbers you get on the list (of priorities)...” 
(D3_2). 
“…You have to measure the benefits and the cost of any 
program and if the benefits are greater than the cost then it’s 
a priority, you should do it...” (DAP_ HIV_2).
At the national level, some respondents reported a reliance 
on broadly generalizable data, which can be applied across 
countries and regions. 
“…So most people are not using evidence, what most 
people are relying on is what the global conventions said we 
should do…” (MOH_Vaccines_1).
However, some respondents noted that contextualizing the 
quantitative data provided by the international community 
can be difficult without the necessary technical competence, 
which further contributes to their reliance on international 
experts in making use of data. 
Qualitative Evidence
Unlike national-level respondents, who tend to focus on one 
program, sub-national decision-makers tend to focus on 
evidence that can help facilitate program implementation 
across a range of areas within the healthcare system (HCS). 
Three district level respondents in this study noted that it is 
important to look beyond the quantitative evidence if priority 
setting and program implementation are to succeed. These 
gave an example of HIV whereby they alleged that successful 
interventions must incorporate cultural preferences and 
political demands alongside measurable factors such as 
effectiveness. If costs were the sole metric by which priorities 
were set, abstinence-based education would be the best 
approach for HIV prevention. However, a more complex 
picture, that requires decision-makers to account for a 
range of political and socio-cultural needs, emerges when 
information such as beneficiary assessment data and cultural 
preferences are considered.
Acknowledging this, 4 district level respondents mentioned 
the value of data that incorporates local views, which can be 
collected through approaches such as conversations between 
the public and service providers; through the involvement 
of community resource persons; via suggestion boxes at 
health facilities, exit interviews in clinics, and community 
satisfaction surveys.
However, some respondents were concerned about the 
difficulties in assessing the quality of and integrating this 
qualitative information in actual decision-making;
“….I know that there have been big discussions in the 
organization related to how to try to measure a contribution to 
for example all activities on communication for development 
that are related to changing behavior, other things which are 
also very difficult to measure beyond process indicators…” 
(DAP_HIV_3). 
The Sources of Evidence 
Respondents identified several sources of the evidence they 
used in priority setting at the national and district levels. 
These included; Policy documents and Reports; Special 
research and “experts.”
Policy Documents and Reports
Respondents identified several policy documents and 
reports they used as sources of evidence for healthcare 
prioritization. These included national health policy and 
planning documents, Strategic plans, annual review reports 
and national statistics. Respondents also identified specific 
performance reports generated through monitoring and 
evaluation mechanisms such as the Health management 
information systems from the districts and lower levels, 
biannual reviews (one respondent), in addition to monitoring 
indicators set in strategic and work plans (one respondent). 
Furthermore, respondent discussed large-scale sector reviews 
eg, the Health Financing Review, (which explored 11 domains 
including health financing, performance, and efficiency of 
interventions) and the National Health Accounts survey done 
in 2009/2010 which provided trends and relative proportions 
of government outlays, donor outlays but also other sources 
of funding like Out of pocket expenditure. 
“…the performance reports are available – the Ministry 
does performance evaluation every 6 months – we used to do 
it quarterly but found that it was a bit too frequent” (MOH_
HIV_3).
Research
Respondents discussed research and special studies as an 
additional source. Specifically, several respondents discussed 
how the results from the burden of disease study though 
dated, still played an important role. Other specific studies 
include beneficiary assessments and specific program reviews 
and assessments;
“The global burden of disease study, the burden of disease 
study that was done for Uganda in 1993 still influences very 
much the priorities and the interventions therein that are 
used for the health sector…” (DAP_HS_2).
“Well it is the middle level and high level managers 
within the organization who regularly review program data 
and based on that program data they’re going to identify 
priorities...” (DAP_MNCH_5).
Furthermore, interviewees articulated using locally 
produced evidence in the form of statistical assessments 
of the resources, databases, and other studies conducted 
at the different levels within the health sector, pilot studies 
(for example the malaria interventional studies and 
performance based financing studies), consumer satisfaction 
and governance surveys. In addition to these, respondents 
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reported using evidence on the successes and failures 
experienced by similar African countries for transposable 
interventions, programs, and lessons.
“…We can also look at the East African community in 
general how are the other member countries performing? 
Like in Rwanda, how have they improved their health 
indicators? We see if we can cut out (implement) those kinds 
of interventions, maybe we can (also) improve” (MOH_ 
HS_12).
In contrast some respondents discussed the significance of 
international evidence; 
“… International evidence plays a major role in driving 
local action and…maybe for many reasons (such as) it is 
published in the lancet, the WHO has endorsed it…” (MOH_
NCD_3).
While they recognized the importance of international 
evidence, respondents also highlighted the need for 
increased support for systematic gathering and use of local 
evidence. This limitation was emphasized by the district 
level respondents who talked about how limited resources 
hampered the generation of local evidence.
Experts
Consultative meetings with local and international experts 
were undoubtedly the most commonly stated medium 
through which evidence, expertise, and recommendations 
were generated. These meetings occur between diverse and 
numerous stakeholders within the Uganda health sector, 
including but not limited to: donors and other development 
partners, experts and specialists, district-level health officials, 
service- and care-providers, and community members/
service users. The purpose of these meetings are to generate 
thorough knowledge of the health sector performance, 
understand where action is required, and to determine the 
most appropriate interventions; 
“…technical working groups…people come with 
presentations, people come with a new areas of research, 
people come with new evidence…most of the work on 
priority setting is done at the technical working group…
by experts, knowledgeable people that’s where most work is 
done” (MOH_ MNCH_9).
“At community level we create a forum for communities 
to have an honest discussion with the service providers and 
make sure that what they are doing responds to their needs” 
(DAP_HIV_4).
DAPs, based on their technical and extensive infrastructure, 
were somehow expected to provide and to facilitate the 
gathering of evidence:
“…Evidence is a big issue and it should be, from a technical 
perspective, it’s really their (DAPs) role to … strengthen 
and build that evidence base in order to provide it during 
the resource allocation, prioritization processes…” (MOH_
HIV_1).
The above sources of evidence were corroborated by 
respondents from the districts, who in addition to the above 
sources, and possibly due to their proximity to the community, 
identified the public (through their local representatives), 
and non- government organizations as additional sources of 
evidence.
The Role of Evidence in Priority Setting 
When discussing the role of evidence when setting priorities, 
respondents from the national and district levels had varied 
perspectives. While several reported specific aspects of the 
prioritization process where evidence was reportedly used, 
some respondents doubted that evidence played a big role in 
the process.
When discussing how evidence is used in the prioritization 
processes, the responses were similar at both levels and 
included; 
(i) When assessing the effectiveness of program 
implementation - where monitoring and evaluation evidence 
is collected, 
“…We majorly use data because data shows the gaps. 
Remember, yes the resources are limited but our gaps are 
saying - our data is saying there is a gap, this sub county does 
not have a maternity ward, we as government go in to make 
sure the sub county gets a maternity ward…” (D2_09).
Certain epidemiological indicators can also give insight 
into how well programs are performing at the local level and 
can influence priorities that are set by an organization that 
is involved in implementation. One respondent explicitly 
described that priorities should be based on the needs of the 
population, which can be inferred from statistics that reveal 
gaps in care and service. 
“But at the end of the day, as I said, we need to know how 
quickly do you diagnose a patient, how much time do you 
ensure you put in to getting them treated and followed up 
to completion. So the indicator in that case would be case 
detection rate. Case identification rate, extreme access rate, 
cure rate, and the others...” (DAP_HIV_5).
(ii) Evidence was also reported to be used; to guide strategic 
planning, when identifying priority interventions, and in 
advocating for more resources.
The use of evidence in planning was reiterated by district 
level respondents who provided additional examples of how 
they use evidence to identify and prioritize underperforming 
facilities, 
“The biostatistician compares up to date records of the 
entire department per sub-county, per health unit, and in 
such…we have all the success registered, the failures and the 
challenges also registered, and then we use such records to 
guide the planning, to guide priority setting, per facility...” 
(D2_2).
 (iii) Respondents also discussed how evidence was used 
to improve the quality of their decisions by limiting the 
role of self- interest. For example, district level respondents 
discussed how they use evidence to differentiate between the 
community’s real needs from their expressed needs; 
“…People can express this need but if you go down 
you’ll find the real need is actually not the one they have 
expressed…the direction is to always generate evidence to 
support those expressed needs so that we are able to allocate 
resources a lot better…” (D1_1).
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Two respondents emphasized the importance of evidence in 
successful priority setting pointing out the ways in which a lack 
of evidence can hamper evidence-informed priority setting. 
Without evidence to set priorities, and without evidence to 
evaluate the degree to which the priorities are implemented, 
effective priority setting can be difficult. 
Challenges Related to the Use of Evidence in Priority Setting
Respondents reported a range of challenges that hinder the use 
of evidence in priority setting. In particular, they highlighted 
challenges related to (i) the availability and access to evidence, 
and (ii) challenges related to the use of evidence in priority 
setting, all of which are discussed. 
Challenges Related to the Availability and Accessibility of 
Evidence 
In discussing the use of evidence for priority setting, lack of 
evidence was identified as one of the main challenges;
“….We sometimes set priorities not based on evidence but 
based on experience. The challenge is to get the data, analyze 
it and help us in priority setting…” (MOH_MNCH_5).
Respondents discussed how poor physical infrastructure, 
political upheaval, and natural disasters can make it 
difficult for them to reach the areas where data is to be 
collected. Deficiencies in infrastructure can be particularly 
problematic when location-specific information is required 
yet some locations may be inaccessible due to poor physical 
infrastructure. 
As respondent from the emergency program explained,
“…I find that sometime it is hard for the committees 
to visit to the community due to lack of the transport…” 
(MOH_Emergency_05).
Respondents also discussed financial and personnel 
related challenges. For example, one national-level 
respondent highlighted how limited resources can hinder 
the implementation of country-specific studies. This was 
discussed in reference to other programs that have more 
resources:
“…They (other people) have the resources and people 
to invest in to do a good job in packaging, delivering, 
and influencing. If you look at me (from the MOH) what 
resources do I have to do a good study and disseminate it? 
Where do I get those resources?” (MOH_MNCH_1).
While adequate funding has facilitated the availability 
of evidence for programs such as HIV, inadequate funding, 
makes it difficult for policy-makers to generate the evidence 
needed to support decision-making in relatively under 
resourced programs. 
Challenges Related to the Actual Use of Evidence in Priority 
Setting 
Respondents discussed several factors that affect the use 
of evidence. These were either related to the evidence 
(completeness and credibility) or to the different stakeholders 
(interests and the pressure to implement).
The Completeness and Credibility of the Evidence
One challenge identified by most of the respondents was the 
incompleteness of the available information. For example, 
respondents spoke about how they lacked national and sub-
national denominators, which numbers would allow priority 
setters to make inferences about a population: 
“…What we usually have [are] numerators … and you 
don’t have information for decision-making because you 
don’t even have the denominators you just have some 
numbers…” (MOH_HS_14).
It can be difficult to set priorities that are in the interest 
of the whole population if basic demographic information 
is not available to provide a clear picture of the population 
being served, or if such evidence has been manufactured or 
distorted.
While some of the respondents recognized the relevance of 
qualitative evidence in providing a complete understanding 
of the health problems, they noted that it can be difficult 
to incorporate evidence that is not easily quantifiable into 
an evidence-informed priority setting process. However, 
omitting qualitative evidence means that sometimes decisions 
are based on “incomplete” quantitative evidence which may 
not provide a complete picture of the situation. 
Although sometimes the decision-makers have access to 
complete information, the credibility of some of the evidence 
is doubtful. For example, one national-level respondent, 
talking generally about GAVI funding, reported an instance 
where they think imaginary numbers were used for funding 
purposes:
“… So, it’s happened all the time, if you take GAVI 
application from countries there are many applications where 
you have the data on vaccine coverage that were just made 
up just for the sake of getting money…” (DAP_Vaccines_6).
Another aspect of the credibility of evidence, is timeliness. 
Respondents were concerned about having to use out dated 
information to guide priority setting. These specifically 
discussed instances where outdated evidence (such as the 
BOD/CEA study), continues to be used in priority setting.
“…The global burden of disease study, the burden of disease 
study that was done for Uganda in 1993 still influences very 
much the priorities and the interventions therein that are 
used for the health sector…” (DAP_ HS_2).
Respondents from the HIV and vaccines programs also 
cited problems with keeping up with incoming data. In 
particular, they noted the challenges in staying up-to-date 
with and subsequently applying the findings from ongoing 
scientific advances, which evolve at a faster rate than they 
can process. Conversely, other respondents discussed how 
sometimes researchers take a long time to generate the 
required evidence. In such instances, the research evidence 
tends to be out of synch with decision-makers’ timeframe, 
hence forcing the policy-makers to make decisions that may 
not be informed by the most recent evidence: 
“…A huge challenge is that the implementation and 
policy-making move at a different pace than research …. I 
think that there’s always a tension to find better, quicker and 
more useful ways to [generate research and information] on 
a continuous cycle because it is … unsatisfactory to only be 
able to rely on a baseline and an end line, and maybe if you’re 
lucky a midline, because, over a five-year project, things are 
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moving and changing more rapidly…” (DAP_MNCH_3). 
Challenges Related to the Different Stakeholders
This section focuses on respondents’ discussions of how 
donor priorities, government priorities, and local priorities 
and interests can interfere with the use of evidence in priority 
setting. There was a feeling among the respondents that donor 
agendas can lead to a rearrangement of the priorities, even 
when priorities are based on sound evidence. Governments 
can also be guilty of using their authority to steer priority 
setting. Two respondents criticized politicians at both the 
national and sub-national levels for prioritizing their own 
interests: 
“…So sometimes the evidence is overlooked …. Budgeting 
and resource allocation are done from a perspective that 
looks at balance of delivery—vis-à-vis the perspective of 
other colleagues on the political scene…” (D1_3).
To compound this problem, respondents pointed out that 
well-intentioned politicians who want to make use of evidence 
for the prioritization process may not always have the capacity 
to interpret and apply the information at their disposal.
Personal-interests (at the individual or organization level) 
can also hinder evidence-informed priority setting. National 
and district level respondents discussed how local partners- 
especially donors- sometimes push priorities based on their 
own beliefs, preferences, and needs, in spite of the evidence. 
Furthermore, they noted that individuals also tend to 
prioritize health issues that, in one way or the other, has or 
might affect them. 
“…I think people set priorities when they are endangered. 
For example, if you feel you are at risk for something then 
you tend to … put priority on that something …. Ideally, it 
should be according to the figures, the burden of disease and 
statistics...” (MOH_HS_5).
Challenges can also occur in the transition from acquiring 
evidence to implementing solutions. In particular, respondents 
highlighted how a desire for quick solutions, and hence 
implementation, can override the use of evidence. When 
decision-makers think they know the solutions (possibly 
based on their experience), generating evidence seems a waste 
of time and resources. The tendency is to quickly implement 
the known solutions, even though they are not supported 
with credible evidence:
“…People think why waste money doing a lot of appraisals, 
a lot of studies, a lot of analytical work. We want money for 
actions because we know what the problems are. But you 
know what the problems are in a small way, and you do not 
know how that same problem translates three, four, five years 
down the road, which is critical, otherwise after four years 
you’re coming back to the same problem. So, getting that 
across has been quite a challenge…” (DAP_HS_5). 
A secondary challenge related to the generation and 
use of evidence in healthcare prioritization is the failure 
to implement the identified priorities. As implied in the 
above discussion, policy-makers tend to weigh the costs 
and benefits of investing in gathering evidence; especially if 
the possibility that the evidence-informed priorities are not 
feasible. Logistics eg, limited human resources, can stand in 
the way of the resultant priorities’ deployment:
“…For example, we may have … evidence that male 
circumcision works, and so you want to support the delivery 
of that service … but you find there are no surgeons. If there is 
a surgeon, there are no theatre materials. If there are theatre 
materials, there’s no post recovery management or supplies. 
You find that the entire system has gaps…” (DAP_HIV_2).
Just as a lack of resources poses a problem at the start of the 
evidence-gathering process, a lack of resources or personnel 
can stand in the way of implementing the solution based on 
the priorities that have been established.
Despite the obstacles to evidence-informed priority 
setting, respondents from both the national and sub-
national levels reported successes that stemmed directly 
from using evidence. For example, some discussed how 
evidence helped priority setters overcome limitations, and 
how in some projects evidence had been used to successfully 
establish health priorities. Evidence-weighing processes 
resulted in the establishment of reproductive health related 
priorities. Furthermore, the use of evidence related to disease 
epidemiology, resources, local populations, and cultural 
practices resulted in successful evidence-informed health 
system prioritization:
“…we did a lot of research … to come up with evidence-
informed interventions. Starting from baseline in the 
countries where we were working, we saw, for example, 
malaria, pneumonia and diarrhea which were the main 
causes of child mortality, and the most important thing was 
to really have health workers who were not only specialized 
doctors but could train in a short period of time to diagnose 
these illnesses and treat them in an easy way. We found that 
also culturally, traditional attendants and midwives were 
very useful for these [purposes], so we said let’s study how 
effective it would be to prevent illnesses, cure diseases, and 
save lives by training these kind of health workers…” (DAP_
MNCH_3).
 While the results are presented individually and 
sequentially, they are interrelated. For example, the lack 
of resources will impact the availability and quality of 
evidence, its completeness, quality and even the timeliness. 
Furthermore, how decision-makers define and attribute 
value to the different kinds of evidence may influence their 
willingness to invest in gathering either the qualitative or 
quantitative evidence. The lack of resources may introduce 
stakeholders with resources, who, by virtue of controlling the 
resources, also introduce self-interest in setting priorities at 
the expense of what the evidence dictates. The pressure to 
implement hampers evidence-informed decision-making. 
However, the pressure to implement could also contribute to 
the incompleteness of the evidence – whereby the producers 
of evidence are also under pressure to produce some kind of 
evidence for the decision-makers. 
Discussion
We presented findings from an empirical study on how 
decision-makers at the national and sub-national levels 
conceptualize, access and perceive the utility of evidence 
when setting healthcare priorities. Respondents used different 
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terminologies to define evidence. They access the evidence 
through documents, research and experts. Although there 
was interest in using evidence, respondents at the national 
and district levels reported varying challenges related to 
their access to and use of evidence when setting healthcare 
priorities. 
The study findings that decision-makers have an interest 
in- and endeavor to use evidence when setting healthcare 
priorities, in healthcare programming, implementation, and 
in program evaluation are consistent with the literature on 
evidence-informed decision-making.5,8,20,21 It was beyond 
the scope of the paper to establish if and how the decision-
makers actually used evidence when setting healthcare 
priorities. Some of the literature on how decision-makers 
actually use evidence discusses the impact of the decision-
making contexts and cases where evidence is used to support 
already made decisions as opposed to guiding the decision-
making processes.37-40 However, if the decision-makers we 
interviewed are genuinely interested in using evidence to 
guide their prioritization process, the interest may present 
an opportunity for augmenting the use of evidence, if the 
identified barriers are addressed. The barrier of limited 
capacity (human and financial resources) to collect evidence 
which results in generating of poor quality and incomplete 
information which in turn affects the use of evidence; have 
been discussed in the evidence-informed policy-making 
literature.41-43 The importance of good quality and timely 
evidence cannot be overemphasized. Poor quality of the 
evidence, timeliness of the evidence, the relevance of the 
evidence – with emphasis on the context where the decisions 
are actually made are some of the key limitations to the use of 
evidence in policy-making in many LICs.10,14,19,43-47 While lack 
of resources may account for the poor quality of evidence, 
exploring ways through which well-funded programs such as 
Vaccines—could be leveraged to strengthen the evidence base 
across the health sector would be beneficial.48,49 This is more 
so since program implementation at the district level is often 
under the same umbrella and vertical information gathering 
may prove to be resource intensive. 
Since all sub-national (districts) have a health information 
officer who is responsible for synthesizing district level 
information, it may be useful that these individuals are 
supported to effectively accomplish their duties. Capacity 
strengthening and supporting these individuals to assume 
leadership in all information gathering within the district, 
may contribute to more efficient use of the available resources 
to collect high quality evidence.47 At the national level, 
the existing resource center should be supported with the 
necessary human resources with the capacity to manage an 
integrated health information system for all programs.28,29 
Focused and integrated capacity strengthening and support 
would alleviate some of the additional barriers of poor quality, 
completeness, and timeliness.
However, there were subtle differences between responses 
from the national and sub-national levels and between 
respondents from the different programs, which are worth 
discussing. 
First, relative to the district level respondents, national 
level respondents were more likely to conceptualize evidence 
in terms of quantitative measures and to value this kind of 
evidence relative to qualitative evidence. The reasons and 
uses of this kind of evidence (for example as an advocacy 
tool) may be more critical at the national level.46 Most of the 
resource mobilization and allocation for the health sector 
occurs at the national level. At that level, measurable, and 
easily quantifiable evidence tends to be valued, it may be more 
difficult to make a case based on unquantifiable, let alone 
measurable problems.4,45,46 Furthermore, decision-makers at 
the national level tend to be appointed technocrats who are 
relatively removed from the populations they serve.29,33,50 
Conversely, while some of the sub- national decision-makers 
are also technocrats, several are elected. Even the technocrats 
have to be vetted by the political appointees.50 There might 
be pressure for them to listen to, and consider the public’s 
interests—which tends to be more qualitative. Conversely the 
sub-national decision-makers are the legitimate implementers 
of the health programs.16,29,47,50 Their proximity to the 
population and their mandate may compel them to appreciate 
the qualitative evidence so as to respond to the needs of the 
populations they serve. 
Second, national-level respondents focused on evidence-
informed priority setting with respect to policy formulation 
and program evaluation. By contrast, sub-national–
level respondents focused on the use of evidence for the 
implementation of policy.16,17 This means that priority setters 
at the 2 levels are often using evidence to different ends. 
Where national-level priority setters rely on evidence to 
guide higher order decisions about what policies to fund, sub-
national–level priority setters are using evidence to determine 
practical solutions for enacting these national-level policies. 
As such, there is a gulf separating the uses of evidence even if 
the evidence being used is the same. This can create multiple 
demands on a single set of evidence, and can even lead to 
conflicting ideas about what should be done depending on 
the ends to which the evidence is interpreted. 
Third, there was a perception that the evidence at the 
sub-national level was of relatively poor quality while that 
at the national level—especially that collected through 
reports—was of relatively better quality. This perception 
was surprising given the ideal hierarchy of decision-making 
within the decentralization framework. Ideally, the sub-
national evidence should be pulled together to form basis for 
the national level decision-making processes.29,33,48 Hence if 
the sub-national level evidence is of relatively poor quality, 
it should impact the quality and completeness of the national 
level evidence.18,49 Conversely, this may be a reflection of the 
differences in the quality of data, between the districts; and the 
sampling strategy used in the study. The country has over 100 
districts and only 3 were included in the study. It is possible 
that the findings are a reflection on only a small sample which 
may not impact the overall quality of evidence at the national 
level—where data from all districts are aggregated. However, 
this may also be a true reflection of the shortcomings in 
resources, infrastructure, and personnel capacity at the sub- 
national level—which need to be addressed.16,17,43
The factors that compete and sometimes trump the use 
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of evidence when setting healthcare priorities have been 
documented in the literature. Some of the literature alludes to 
the perceptions that factors such as politics, popularity; may, 
in some cases, be perceived as more critical – at least to the 
decision-makers – than what the evidence says.51,52 In contexts 
where resources are limited, it is unreasonable to allocate 
resources according to personalist or organizations’ interests 
as opposed to the evidence. However, it is also important 
to note that evidence is just one of the considerations in 
priority setting. There are additional relevant considerations 
which may come into play. The literature on the criteria for 
setting priorities emphasizes the need for enlisting and using 
criteria that are relevant and acceptable to the priority setting 
context.4,53 It may be problematic if the priorities based on 
the agreed upon criteria are contrary to what the evidence 
points to. In some of these cases, unacceptable criteria such 
as personal interests, come into play. Transparency of the 
decision-making processes, including the evidence used, the 
type, and its sources (whose evidence? who was talked to?) 
and how it is used in the prioritization process would enable 
decision-makers and all the other stakeholders to evaluate the 
evidence; against the decisions.53,54 Transparency may also 
deter those who may want to introduce self-interests in the 
prioritization process.
The findings that there were differences in responses 
between the different programs that were sampled was 
interesting. For example, respondents from the HIV, 
Vaccines and MNCH cases; compared to respondents from 
for example the NCDs case; were more likely to report the 
availability of evidence for their prioritization. This finding 
may not be surprising since these programs have enjoyed 
external funding which requires stringent accountabilities. 
In many cases the accountability should be supported with 
evidence and the funding agencies support the gathering 
of this evidence.16,17,30-32,55-58 As discussed above, it would be 
efficient for the health system to leverage the resources and the 
health information structure set up for the funded programs 
to benefit the less well-funded. Furthermore, respondents 
from programs such as HIV and Vaccines- seemed more 
appreciative for qualitative information—which might be 
a reflection of their experiences with the various types of 
evidence.59-61 Qualitative evidence, which accesses personal 
experiences play a big role in the acceptability of interventions 
as were the case of HIV control, and new vaccines. 
Limitations
The findings of this study should be interpreted with caution. 
Since this was a qualitative study involving a sample of 
respondents from 6 programs at the national level, and 3 
districts, we cannot claim that the findings are generalizable. 
However, the purpose of the study was to provide in-depth 
understanding of the use of evidence and not generalization. 
We however, observed the validity standards for qualitative 
data collection and reporting and hence believe the findings 
are credible and make meaningful contribution to the 
literature on the use of evidence within these programs’ 
priority setting.
Conclusion
While there is interest in using evidence in priority setting 
presents an opportunity for augmenting evidence-informed 
priority setting, problems with collecting, accessing and 
interpreting data, and several barriers that make it difficult to 
translate evidence into meaningful, practical priorities. Hence, 
decision-makers in LICs need to invest in improving the 
availability of high quality evidence and committing to its use 
when setting healthcare priorities. At the district level, there 
is a need to invest in systematic collection of both qualitative 
and quantitative information right from the community, 
to the health units. Encouraging the use of this evidence at 
the level at which it is collected may increase the interest in 
collecting it. District level information should inform national 
level priority setting. Similarly, national level decision-makers 
should strengthen the collection and use of both qualitative 
and quantitative evidence gathered from all the districts 
within the country. In the mean time, decision-makers should 
be encouraged to use the based available evidence to improve 
the quality of the priority setting decisions. 
Since lack of quality evidence is more prevalent in some 
of the health programs (due to different funding models), 
decision-makers should leverage the resources available in 
the well-funded programs to harmonize the generation and 
use of evidence in priority setting across the HCS. 
The subtle differences in the availability and use of evidence 
in priority setting across the health programs within the HCS 
highlight the need for similar studies in other LIC HCSs to 
substantiate and understand the nature of these differences 
and how they may impact actual health system priorities in 
this era of evidence-informed decision-making and priority 
setting. 
Acknowledgements
This research was funded by the Canadian Institutes for Health 
Research, Ottawa, ON, Canada [Grant 10558616]. The author 
acknowledges the following people for their involvement in 
various aspects of the project: the study respondents without 
whose participation, the study would not have been possible, 
Drs. Ssengooba F., Kiwanuka S. and Kirunga-Tashobya C. for 
providing meaningful insights during the data collection and 
analysis; Sarah Roger, Emmy Arnold, and the various research 
assistants for their participation in the data collection, analysis 
and report writing. 
Ethical issues 
This study was approved by the McMaster Research Ethics Board and 
Makerere University School of Public Health Research Ethics Board and the 
Uganda National Council for Science and Technology. All respondents provided 
signed consent.
Competing interests 
Author declares that she has no competing interests. 
Author’s contribution 
LK is the single author of the paper.
Endnotes 
[1] In this paper we adopt Lavis et al, 2009 understanding of evidence as 
“concerning experience or observations (facts) that are intended for use in 
support of a conclusion.”
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[2] In this paper priority setting is defined as: Process of ranking health 
interventions for resource allocation purposes. Some of the literature uses 
priority setting synonymously with resource allocation.  It occurs at the micro-
level (bedside); meso-level (regional health authorities, health institutions, 
district authorities); macro-level (national government, ministry of health) and 
the global level.
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